- Prev close
- $401.65
- Day range
- $397.72 – $403.97
ISRG’s flat session looks like ordinary noise: the stock closed +0.1% while the S&P 500 was -0.0% and the Nasdaq 100 was +0.8%, with the move anchored more in its durable growth profile than in any stock-specific news.
ISRG
INTUITIVE SURGICAL INC
As of Sep 22, 2026
78/100
Looks healthyHealth ScoreWhy it moved
The move looks market-driven rather than stock-specific: ISRG finished +0.1% while the S&P 500 was -0.0% and the Nasdaq 100 was +0.8%. With no fresh company event in the facts and no sector peer move provided, the clean read is that this was essentially a flat session in line with a firm growth-tilted tape, not a company-specific break.
Normal volatility?
Yes — this fits ordinary volatility for a high-quality but expensive growth stock. Revenue is +20.7% YoY (TTM), the latest quarter is +18.5% YoY, and EPS is +21.8% YoY (TTM), so the operating picture is still strong; gross margin is +66.7%, operating margin is +31.3%, and net margin is +28.4%. But valuation is rich at PE 45.1, forward PE 30.6, and PEG 2.42 — a PEG of 2.42 means investors are paying 2.42× the growth rate, so good news is already partly priced in and the shares can move more than the business does. Beta is 1.48, which also points to above-market sensitivity.
Earnings preview
The next earnings date is not available this period, so I can’t place the report on a calendar from the facts here. What is available is the current consensus setup: revenue +20.7% YoY (TTM), latest quarter +18.5% YoY, EPS +21.8% YoY (TTM), with gross margin +66.7%, operating margin +31.3%, and net margin +28.4%. The market will be focused on whether da Vinci procedure growth is still near that pace, whether margins stay near current levels, and whether platform expansion items like the first CE mark in gynecology and the da Vinci 5/AI push are converting into measurable utilization.
This report is for informational and educational purposes only. It does not constitute financial, investment, tax, or legal advice. The platform does not recommend buying or selling any security.
Track ISRG with WhyIHold
Get a plain-English explanation the next time INTUITIVE SURGICAL INC makes a big move — so you know whether it's benign or worth your attention.